Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Anti-TNF therapy can cause hair loss and skin issues.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Blocking interferon-gamma might help treat various autoimmune diseases.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Psoriasis can cause temporary or permanent hair loss.

A patient lost all their hair while on rheumatoid arthritis medication.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Hair loss is common in IBD patients, and some medications may lower the risk.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Managing multiple autoimmune diseases in one patient is very challenging.